Sofia Sandgren

8PUBLICATIONS
23CO-AUTHORS
Economic models and forecastingNeurology and neuromuscular diseasesAutoimmunityMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 26, 2025
Serum GFAP as a biomarker for progression in multiple sclerosis: assay comparison and a large reference database of healthy controls.

Eline A J Willemse, Sofia Sandgren, Pascal Benkert

|Nov 05, 2025
Biomarker discovery using NUcleic Acid-Linked Immuno-Sandwich Assay in multiple sclerosis patients experiencing progression independent of relapse activity.

Sofia Sandgren, Aleksandra Maleska Maceski, Pascal Benkert

|Oct 17, 2025
Lymphocyte Dynamics and the Emergence of Secondary Autoimmunity Following Immune Reconstitution Therapies in Multiple Sclerosis.

Sofia Sandgren, Lenka Novakova, Markus Axelsson

|Aug 04, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response.

Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren

|Feb 18, 2025
Quality of life is decreased in persons with relapsing-remitting multiple sclerosis experiencing progression independent of relapse activity.

Sarah Lindberg, Sofia Sandgren, Markus Axelsson

|Mar 14, 2024
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study.

M Johnsson, Y T Stenberg, H H Farman

Pageof 2

Frequent Collaborators

4 joint publications

Jan Nils Lycke

4 joint publications

Maximilian Einsiedler

4 joint publications

Jens Kuhle

3 joint publications

Igal Rosenstein